Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPension (IS)Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repaymentsWages, Salaries and Other
Ratios

Harvard Bioscience (HBIO) Leases (2019 - 2025)

Harvard Bioscience (HBIO) has disclosed Leases for 7 consecutive years, with $7.2 million as the latest value for Q4 2025.

  • Quarterly Leases rose 16.96% to $7.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.2 million through Dec 2025, up 16.96% year-over-year, with the annual reading at $7.2 million for FY2025, 16.96% up from the prior year.
  • Leases for Q4 2025 was $7.2 million at Harvard Bioscience, down from $7.5 million in the prior quarter.
  • The five-year high for Leases was $7.5 million in Q3 2025, with the low at $4.4 million in Q1 2024.
  • Average Leases over 5 years is $6.2 million, with a median of $6.4 million recorded in 2022.
  • The sharpest move saw Leases dropped 20.82% in 2024, then soared 67.08% in 2025.
  • Over 5 years, Leases stood at $6.9 million in 2021, then decreased by 15.67% to $5.8 million in 2022, then decreased by 17.93% to $4.8 million in 2023, then increased by 28.47% to $6.1 million in 2024, then rose by 16.96% to $7.2 million in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $7.2 million, $7.5 million, and $7.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.